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ABSTRACT
This paper describes the mathematical modelling of a part of the blood coagulation mechanism. The model
includes the activation of factor X by a puried enzyme from Russel's Viper Venom (RVV), factor V and
prothrombin, and also comprises the inactivation of the products formed.
In this study we assume that in principle the mechanism of the process is known. However, the exact structure
of the mechanism is unknown, and the process still can be described by dierent mathematical models. These
models are put to test by measuring their capacity to explain the course of thrombin generation as observed in
plasma after recalcication in presence of RVV. The mechanism studied is mathematically modelled as a system
of dierential-algebraic equations (DAEs). Each candidate model contains some freedom, which is expressed
in the model equations by the presence of unknown parameters. For example, reaction constants or initial
concentrations are unknown. The goal of parameter estimation is to determine these unknown parameters in
such a way that the theoretical (i.e., computed) results t the experimental data within measurement accuracy
and to judge which modications of the chemical reaction scheme allow the best t.
We present results on model discrimination and estimation of reaction constants, which are hard to obtain
in another way.
1991 Mathematics Subject Classication: 65C20, 65K10, 90C31, 92C40, 65L05.
Keywords and phrases: Mathematical simulation, blood coagulation, parameter estimation, model discrimi-
nation, interactive modelling.
Note: Work carried out under the project `Modelling of processes in Chemistry' (no. MAS2.6).
1. Introduction
One of the problems encountered in the study of a complicated biochemical process like thrombin
generation in plasma, is that neither the reaction mechanism nor the reaction constants and initial
concentrations are precisely known. The knowledge on the reaction mechanism of the process is ob-
tained mainly through experiments on isolated parts of the system. The elements of the system, i.e.
the clotting factors and their interactions, are separated from blood plasma and their interaction is
studied under circumstances that are necessarily not precisely identical to those under which they
cooperate in plasma. In fact it is not even known whether the reaction scheme that we deduce from
such experiments is indeed the one operative in plasma. There may exist unknown factors or reactions,
and reactions that have been shown to be possible in principle may not occur in reality. An example of
this is the fact that factor X
a
can activate factors V and VIII under experimental circumstances, but
that this reaction does not seem to play a role in clotting plasma [MT90]. Also the reaction conditions
y
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in plasma are dierent from those used for the study of the interaction of isolated factors. They may
even be unsuitable for the study of such interactions. The kinetic parameters of activation of factor V
by thrombin, e.g., can not be measured directly in plasma because the presence of natural thrombin
inhibitors renders it impossible to achieve a xed enzyme concentration.
In this article we introduce mathematical model validation and parameter estimation as a possible
solution to these problems. In this procedure, on basis of the existing biochemical knowledge, a proba-
ble reaction mechanism is postulated. This is transformed into a set of dierential-algebraic equations,
which contains unknown parameters. These parameters correspond with the reaction constants and
initial concentrations of the reactants, both approximatively known from previous experiments and
used as an initial guess for the parameters to be estimated. Then, one or more results of the reaction
process are monitored, e.g. the course of thrombin concentration in plasma in time after triggering of
the coagulation process, and the parameters in the model are adapted to obtain an optimal t. Dif-
ferent hypothetical reaction mechanisms can be tested in parallel to see which one results in a better
t. If the best t leads to improbably large discrepancies between the computed and the experimental
results, the model is adapted and the validation process is repeated.
In this paper we briey indicate this process of model derivation and validation. In fact, the process
consists of checking a long sequence of improving models, adapted during the process for a wide range
of reasons. The nal model should not only lead to a satisfactory t, but should also be simple, in
accordance with established facts, and {preferably{ it should not contain an unreasonably large number
of parameters. In order to validate the many models and to estimate the corresponding parameters,
an interactive software package for parameter estimation on a fast computer is an indispensable tool.
Such a computer program, called spIds [EHS95] and partially constructed by two of the authors, was
available to carry out the necessary computations.
The model we consider in this paper describes thrombin formation, a part of the blood coagulation
process, by a system of dierential-algebraic equations. The variation in time of the concentrations of
each reactant is described by a (dierential) equation. The chain of reactions which leads to thrombin
starts with the activation of factor X by RVV, followed by the activation of factor V, the production
of prothrombinase in the presence of phospholipid and the activation of prothrombin. We also take
into account the inactivation of the factor Xa by anti-thrombin III (ATIII) and the inactivation of
thrombin by ATIII and 
2
-macroglobulin (
2
M).
A description of the experiments used is given in Section 2, followed by a derivation of the reaction
mechanism in Section 3. The step from reaction mechanism to mathematical equations is given in Sec-
tion 4. The parameter estimation process is briey described in Section 5. The results and conclusions
are given in Section 6 and 7, respectively.
2. Experimental Data
In order to obtain the required data, four experiments were performed, which resulted in four series
of measurements. The output of the system used for our tests was the course of thrombin-like ami-
dolytic activity. This activity is caused by two types of molecules: thrombin itself and the thrombin-
2
macroglobulin complex (briey denoted as II
a
and II
a
 
2
M respectively, in the reaction scheme, Figure
1).
The data were obtained as follows. To 240 l of debrinated plasma, in which the clotting factors
are contained, we add 3.6 l of a suspension of procoagulant phospholipids (1 M) and 80.4 l of a
solution of RVV. This concentration of RVV was halved in the subsequent experiments. The thrombin
generation process was started at t = 0 by addition of 36 l of CaCl
2
(100 mM). At dierent time
intervals, more frequently in the initial phase of the reaction and less frequently at the end, we took
0.01 ml samples from the reaction mixture and added it to 0.49 ml of a solution of the chromogenic
substrate S2238 (0.5 mM) in a buer that contains the Ca
+
2
chelating agent EDTA in order to stop
further thrombin generation. Thrombin and 
2
M-thrombin split the yellow-coloured para-nitroaniline
from S2238. After 2 min. this reaction is stopped by adding citric acid and the colour is measured
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and used to determine the thrombin activity in the sample. Time measurements for the thrombin
generation are made automatically and samples are taken until a stable end level of amidolytic activity
is observed. This takes about 15 minutes.
3. Reaction Mechanism
At this point we rst present a commonly accepted reaction sequence for thrombin generation in
Figure 1. Thereafter we describe three possible variants as found in [Hem93]. In this section the
reaction mechanism and its alternatives are given in a schematic way. In Section 4 we give a more
precise description by deriving dierential equations. This is followed by an overview of the motivation
and selection criteria involved in choosing one set of equations in favour of its alternatives.
In the reaction schemes the coagulation factors are denoted by their Roman numbers, the subscript
`a' indicates their activated form, `PL' and `PT' denote phospholipid and prothrombinase, respectively.
`ATIII' and `
2
M' (anti-thrombin III and 
2
-macroglobulin) are responsible for inactivation of the
factors II
a
and X
a
.
X X
a
V V
a
II II
a
ATIII
X
a
−ATIII
ATIII
II
a
− ATIII
II
a
−
α
2M
PTPL
RVV
2α M
X
a
V
a
+ +
r1
r3
r4
r5 r6
r7
r8
r9
r2
Figure 1: The reaction scheme for the part of the blood coagulation studied.
In the scheme of Figure 1, the activation of X by RVV, (reaction r
1
), leads to X
a
, followed by its
inactivation by ATIII (r
2
). Next, factor V is activated by II
a
(r
3
). The factors X
a
, V
a
and PL produce
PT in a reversible association (r
4
and r
5
). Subsequently, thrombin (II
a
) is formed out of prothrombin
(II), either in the presence of PT (r
6
) or of X
a
(r
7
). Finally, II
a
is inactivated either by 
2
M or by
ATIII (r
8
and r
9
, respectively).
In this study we show that the above scheme is suitable to explain the experimental results. It
summarises the present common knowledge, but it is not necessarily complete and/or unique. We
also investigate a number of possible alternatives. One such alternative concerns the formation of
prothrombinase (PT), not in a trimolecular reaction but as a sequence of bimolecular reactions (Fig-
ure 2). Two other alternatives are given in the Figures 3 and 4. In the former we account for the
existence of the intermediate meizothrombin that in itself has amidolytic activity [BTH
+
95], in the
latter we account for the existence of an intermediate form of the 
2
M-thrombin complex [MFG92].
All proposed alternatives are more complex than the reaction mechanism we start with in Figure
1. By \more complex" we mean that it has more state variables and more intermediate reactions,
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PT
V
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X
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+
V
a
X
a
.
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PL
PL
X
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V
a
+ PL
Figure 2: The alternative reaction scheme to account for prothrombin formation.
II
a
ATIII
II
a
− ATIII
II
a
−
α
2M
2α M
X
a
PT
II
amII
ATIII
II
a
− ATIIIm
Figure 3: The alternative reaction mechanism for the formation of thrombin by the introduction of an
intermediate reactant, meizothrombin (mII
a
).
which implies that they are likely to t better because there are more degrees of freedom available.
In Section 5 we will derive model equations from the reaction schemes and judge by statistical tests
if an increase of the complexity of the model leads to a signicant improvement of the t between the
calculated model responses and the observed data.
II II
a
ATIII
II
a
− ATIII
α
2M II
a
− 2α M
X
a
PT
m IIa− 2α M
Figure 4: The alternative reaction mechanism for thrombin inactivation by 
2
M . Here we assume that
II
a

2
M transforms further into an amidolytic less active form, mII
a

2
M .
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4. Model Equations
From the four reaction schemes as they are introduced in Section 3, mathematical model equations
were derived. It is obvious that the schemes presented lead to dierent sets of equations. But also from
a single reaction scheme various sets of alternative mathematical model equations can be derived. As an
example we consider the reaction r
1
, which is present in all four reaction schemes. The concentrations
of the chemical species are given in nM and indicated by `[ ]'; the time, t, is given in minutes.
The dimension of the reaction constants are derived from these units. The change in time of the
concentration of factor X can be given by the well-known Michaelis-Menten relation:
d[X ]
dt
=  r
1
=  
kcat
X
 [X ]  [RV V ]
km
X
+ [X ]
: (4.1)
Although we know from literature that this relation is likely to be valid, it may be replaced by
closely related expressions. In cases where km
X
 [X ] or km
X
 [X ], expression (4.1) transforms
respectively into the alternatives
r
1
= kk
1
 [X ]  [RV V ] ; (4.2)
with kk
1
 kcat
X
=km
X
or
r
1
= kk
2
 [RV V ] ; (4.3)
with kk
2
 kcat
X
. Both alternatives have one parameter less than the Michaelis-Menten relation and,
depending on the ratio km
X
=[X ], they can replace (4.1) without loss of accuracy. A third possible
alternative reads:
r
1
= kk
3
 [X ] ; (4.4)
which follows from (4.2), when RV V -dependence is negligible. Similar alternatives exist for the other
reactions. Together, this leads to a large number of candidate models.
From all these candidates we select that model (or subset of models, if the statistical tests do not
lead to a decisive answer) which, (i) is in accordance with established knowledge in the eld, (ii)
is devoid of irrelevant steps (cf. the Michaelis-Menten reaction mentioned above), and (iii) ts the
phenomena observed.
In Section 5 we will highlight the process of parameter estimation and deal with model validation.
In the last part of the present section we give the set of model equations which was chosen from the
candidates on the basis of the criteria (i)-(iii). This set is one of the possible mathematical represen-
tations for the scheme given in Figure 1. and as such it is an example of the many possible systems
of DAEs. In addition, it describes the connection with the experiments.
The selected system of equations reads:
d[X ]
dt
=  r
1
; (4.5)
d[Xa]
dt
= r
1
  r
2
  r
4
+ r
5
; (4.6)
d[V ]
dt
=  r
3
; (4.7)
d[V a]
dt
= r
3
  r
4
+ r
5
; (4.8)
d[PL]
dt
=  r
4
+ r
5
; (4.9)
d[PT ]
dt
= r
4
  r
5
; (4.10)
d[II ]
dt
=  r
6
  r
7
; (4.11)
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d[IIa]
dt
= r
6
+ r
7
  r
8
  r
9
; (4.12)
d[IIa
2
M ]
dt
= r
9
; (4.13)
AmAct = [II
a
] + 0:556  [IIa
2
M ] ; (4.14)
r
1
=
kcat
X
 [X ]  [RV V ]
km
X
+ [X ]
; (4.15)
r
2
= ki
Xa
 [Xa] ; (4.16)
r
3
=
kcat
V
 [V ]  [IIa]
km
V
+ [V ]
; (4.17)
r
4
= k
PT
 [V a]  [Xa]  [PL] ; (4.18)
r
5
= k
PL
 [PT ] ; (4.19)
r
6
=
kcat
II
 [II ]  [PT ]
km
II
+ [II ]
; (4.20)
r
7
=
kcat
2
 [II ]  [Xa]
km
2
+ [II ]
; (4.21)
r
8
= ki
IIa
2
M
 [IIa] ; (4.22)
r
9
= ki
IIaATIII
 [IIa] : (4.23)
The concentration of RVV is supposed to be constant during each experiment. However, it should be
noted that [RVV] diers for the dierent experiments. The inactivation of II
a
and X
a
in the presence of
ATIII and 
2
M is modelled by rst order reactions (r
2
, r
8
and r
9
). This implies that the concentrations
of these inhibitors do not occur in the equations.
The available measurements concern the amidolytic activity, which is expressed as the equivalent
amount of thrombin (nM). This means that, in addition to the equations describing the chemistry,
an equation for the amidolytic activity should be added. This equation is given in (4.14). It takes
into account that the amidolytic activity does not only depend on the activity of thrombin (IIa), but
also on the activity of the thrombin inactivated by 
2
M (IIa
2
M). It is known from [Hem93] that the
inactivated form shows an activity of 55.6% of the active thrombin.
In addition to the system of nine dierential equations (4.5)-(4.13), we need the same number of
initial conditions. At the start (t = 0), the initial concentrations of all state variables are zero, except
for [PL], [II], [V] and [X].
5. Parameter estimation and model validation
The system of equations (4.5)-(4.23) contains 13 reaction constants. None of these constants nor the
initial concentrations of the coagulation factors [II], [V] and [X] are known exactly, but they are
assumed to be constant for each experiment. These 13 reaction constants, plus the three unknown
initial conditions, are the quantities we want to determine; the unknown parameters. We summarise
these parameters in Table 2. From the current literature we know upper and lower bounds for the
concentrations of the clotting factors in normal plasma: i.e. [750nM,2200nM] for II, [10nM,30nM] for
V and [70nM,200nM] for X.
The parameters are determined in such a way that the model responses t the measurements in
a least squares sense. Besides the parameters, condence regions for the parameters are derived. For
more details about the numerical solution of the model equations, minimisation of the least squares
criterion and the condence regions the reader is referred to [Hem72] or [Sto96].
To get more insight in our process of model discrimination, we compare each of the four options,
(4.1)-(4.4), in combination with the reactions r
2
to r
9
from Figure 1 as they are described in (4.16)-
(4.23). The expressions for r
2
to r
9
are obtained by a similar process of selection and validation as we
will describe below.
Mathematical Modelling in Blood Coagulation 7
Under the assumption of (4.16)-(4.23) we immediately reject option (4.4), because it implies that
RV V has no inuence on the reaction scheme, which is not in agreement with the experiments.
Under the assumption of (4.16)-(4.23), with one of the options (4.1), (4.2) or (4.3) we compare
the corresponding model performances shown in Table 1. From this table it is obvious that the rst
r
1
# par df S(
b
)
(4.1) 16 104 6460.4
(4.2) 15 105 70203.8
(4.3) 15 105 100511.0
Table 1: Comparison for the three remaining options (4.1), (4.2) and (4.3). We show the number of
parameters (# par), the degrees of freedom (df: the number of measurements minus the number of
free parameters) and the least squares sum (S(
b
)).
alternative performs better than the other two, if we take only S(
b
) into account. In order to decide
if one model performs signicantly better than another, we use the F-ratio test (see Appendix A). To
apply this test to the three remaining options for r
1
, we take the reaction scheme from Figure 1 and
r
2
to r
9
as in (4.16)-(4.23). The relevant data for the F-ratio test are given in Table 1. The test of a
signicant dierence between (4.1) and (4.2) consists of computing the quantity (cf. (A.2))
X
(4:1);(4:2)
=
6460:4=104
70203:8=105
= 0:0929 ; (5.1)
and to check whether this number is between 1=F

2
(105; 104) and F

2
(104; 105), i.e. 0.602 and 1.661,
respectively, for  = 0:01. The ratio (5.1) exceeds the bounds of this region, which means that the
model with (4.1) accounts signicantly better for the phenomena observed. Therefore, r
1
from (4.2)
is rejected. Similarly (4.3) is rejected, because it performs even poorer, as can be seen from Table 1.
Also, the other models which are derived from alternative schemes described in the Figures 2, 3
and 4, have been tested. All these alternatives give rise to models with more state variables and more
parameters. However, following the same strategy none of them turned out to perform signicantly
better.
6. Results
An initial estimate for the parameters consists of an educated guess from the existing biochemical lit-
erature ([Hem93] and references therein). These initial values are given in Table 2. The nal estimates,
and the corresponding condence regions are also listed in this table. For details on the statistics, the
reader is referred to [Sto96]. The sum of squared residuals for the initial estimates was 2:40 10
7
, after
minimisation it was reduced to 6:287 10
3
.
The measurements (120 in total and 30 for each experiment) and the model responses for the nal
estimates of the parameters are given in Figure 5. The plots show a very acceptable t between the
computed and measured values, i.e. a t within the measurement accuracy, which means that the
model gives a suciently accurate description of the measured quantities.
The independent and dependent condence regions as they are listed in the fourth and fth column
of Table 2 show that by far not all the parameters can be estimated within reasonable accuracy. From
the singular value decomposition of the covariance matrix of the parameters (see e.g. [Hem72]), we can
deduce that with the current model and the available measurements 5 parameters (or combinations
of parameters) can be estimated with acceptable accuracy. By making use of other chromogenic sub-
strates, additional measurements for V
a
and X
a
can be obtained in order to estimate more parameters
more accurately.
The parameter km
2
tends to become small during the parameter estimation procedure and the idea
came up to replace the corresponding reaction, r
7
(cf. (4.21)), with kk
5
 [Xa], in order to reduce the
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para- initial nal independent dependent
meter est. est. condence condence
(
ini
) (
b
) regions (

) regions (
y
)
kcat
X
5.0010
3
2.39110
2
5.30110
3
1.96310
1
km
X
4.0010
2
2.36510
1
5.77610
2
6.33510
0
ki
Xa
2.5010
 1
4.53110
0
1.40810
1
3.66710
 1
k
PT
1.0010
 1
1.22910
2
3.11710
5
4.15210
1
k
PL
1.0010
1
8.01410
2
2.03210
6
2.71110
2
kcat
V
1.4010
1
7.84410
0
2.16610
3
1.86210
0
km
V
7.2010
1
1.49710
2
4.26110
4
3.66610
1
kcat
II
2.0010
3
4.38710
1
8.67810
2
2.95610
0
km
II
2.1010
2
6.22510
1
2.14710
2
2.07310
1
kcat
2
2.3010
0
1.24010
1
2.59610
2
9.15010
 1
km
2
5.8010
1
6.14810
 2
2.93710
1
1.63010
1
ki
IIaATIII
1.3010
0
7.85910
 1
5.79410
 1
4.42310
 2
ki
IIa
2
M
1.5010
0
1.76210
 1
4.61110
 2
2.67310
 2
X
ini
1.3310
2
8.12510
1
1.72910
3
7.55610
0
V
ini
1.6710
1
6.71210
0
1.66310
2
5.82110
 1
II
ini
1.3310
3
5.09310
2
2.67710
2
2.11210
1
S() 2.4010
7
6.28710
3
Table 2: Initial guess and nal estimates for the parameters and their condence regions.
number of parameters by one. The corresponding model gave negative results for the concentration
of factor II, which is a consequence of adapting r
7
( the inequality [II ]  km
2
did not hold on the
whole time interval), and was therefore rejected.
The term r
7
is inevitable, because without this term the production of thrombin will not even start.
This can be seen from the reaction scheme of Figure 1 and the fact that the initial concentrations
of II
a
and V
a
are zero. Before the start of the experiments the expectation of the biochemists was
that the activation of prothrombin (II) would be mainly performed by prothrombinase (PT) and that
the contribution of X
a
would be marginal here. In other words: r
7
would be small compared to r
6
and therefore (after initiating the reaction) could be neglected after a few seconds. By investigating
the separate contributions to the thrombin production for r
6
and r
7
during the simulations, we found
that the contribution of r
7
is about 50% of the production by r
6
and therefore not negligible. This
conclusion should, however, be strictly limited to the case of RVV as a factor X activator and be
extrapolated to other experimental setups.
Although the results of Table 2 may look poor with respect to the condence regions, it appears
that with the current data we were able to discriminate between many models in a systematic way
and to come up with a model which ts the observations satisfactorily.
7. Conclusions
In this paper we compare a number of possible reaction schemes which describe part of the blood
coagulation mechanism. For each scheme mathematical model equations have been derived and pa-
rameters have been adapted in order to obtain a best t with a set of experimental data. Depending
on the complexity of the model, and the quality of the t, judged by the statistical criteria, we were
able to discriminate between many candidate models. The nal model is compact, meets the estab-
lished knowledge in the eld and ts the measurements satisfactorily. A large number of more compact
models were rejected on the account of the measurements. More sophisticated models were rejected
because the increase of complexity did not account for a sucient improvement of the t.
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Figure 5: Plots of the measurements (`+') and the model responses for the nal estimates of the
parameters from Table 2 over the 4 experiments with decreasing concentrations of RVV.
With the nal model selected not only its parameter estimates are presented, which are optimal in
a least squares sense with respect to the available data, but also the corresponding condence regions.
Additional experiments can make the condence regions smaller, but they may also lead to a more
complex model in favour of one of the alternatives which had to be rejected in this paper.
In this sense the presented model can be a good starting point for ongoing research and may show
its value when more experimental data are available.
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A. F-ratio test
We refer to [Rat83] for an introduction to the statistical tests which should be performed and help
the modeller to decide what parameters can be skipped or what model should be chosen. When we
have two models with approximately the same t, the model with the fewest parameters is favourite
for further investigation. What we mean by approximately will be made more precise below.
Suppose we have two solutions coming from dierent models
y(t; ) and z(t; ): (A.1)
We use n
y
andm

for the dimension of y and , respectively. The dimensions of z and  will be denoted
by n
z
andm

. In general, dierent models describing the same physical process have dierent numbers
of state variables or parameters. The only restriction is that the vectors y and z both contain the state
variables for which measurements are available.
From the two models we get optimal parameters and corresponding sums of squares:
b
,
b
, S(
b
) and
S(
b
). From the normal assumption with respect to the measurement error, and assuming that the
optimal parameters are close to the true parameters, we know that:
X =
S(
b
)=(N  m

)
S(
b
)=(N  m

)
 F(N  m

; N  m

) : (A.2)
Where F(p; q) denotes the Fisher's F distribution with p and q degrees of freedom respectively. From
the characteristics of an F distribution we know:
E(X) =
N  m

N  m

  2
; (for: N  m

> 2)
and
P

1
F

2
(N  m

; N  m

)
 X  F

2
(N  m

; N  m

)

= 1   ;
where F

2
(N  m

; N  m

) is the upper =2 quantile for Fisher's distribution (see e.g. [MGB74]).
Notice that the expectation of X does not depend on m

. When the two models have about the same
performance, X will be close to its expectation. Whenever X exceeds F
=2
(N  m

; N  m

), which
means that S(
b
) is signicantly larger than S(
b
), the model which corresponds to y(t; ) is rejected
in favour of the model which corresponds to z(t; ). Of course, the opposite happens if X is less then
1=F

2
(N  m

; N  m

). In all other cases no conclusion can be drawn, although if there is a model
with less parameters, then this one is favourite for reasons of compactness.
